Fennec Pharmaceuticals Inc.

NASDAQ:FENC

Biotechnology

Healthcare
$13.33 -1.34%

-$0.12 today

Market cap
$470.62M
Beta
1.08
P/E (TTM)
-36.3
EPS (TTM)
-$0.24
52W Low $5.65High $10.45

Volume 0.59M

Average 0.26M

Income Statement

Follow revenue through to earnings.

Revenue

$44.64M

FY 2025 · Annual

-6.1% YoY

Operating Income

-$6.35M

FY 2025 · Annual

Net Income

-$9.74M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue01.54M21.25M47.54M44.64M
Cost of Revenue086K1.26M3.18M3.76M
Gross Profit01.45M19.99M44.35M40.88M
Gross Margin—94.4%94.1%93.3%91.6%
Research & Development4.98M3.53M56K307K250K
Selling, General & Admin12.24M20.51M32.71M41.48M46.91M
Operating Expenses17.22M24.19M33.05M41.88M47.22M
Depreciation & Amortization16K149K287K800K103K
EBITDA(17.22M)(22.59M)(12.36M)4.8M(7.45M)
EBITDA Margin—-1471.5%-58.2%10.1%-16.7%
Operating Income(17.22M)(22.74M)(13.06M)2.48M(6.35M)
Operating Margin—-1481.3%-61.4%5.2%-14.2%
Interest Income54K195K441K1.59M787K
Interest Expense126K978K3.39M4.07M2.08M
Other Income / Expenses(123K)(976K)(2.99M)(2.55M)(3.29M)
Income Before Tax(17.35M)(23.71M)(16.05M)(71K)(9.64M)
Pre-Tax Margin—-1544.9%-75.5%-0.1%-21.6%
Income Tax Expense000365K106K
Net Income(17.35M)(23.71M)(16.05M)(436K)(9.74M)
Net Margin—-1544.9%-75.5%-0.9%-21.8%
EPS (Basic)(0.67)(0.95)(0.60)(0.02)(0.36)
EPS (Diluted)(0.67)(0.95)(0.60)(0.02)(0.36)
Weighted Avg Shares26.01M26.28M26.57M27.29M28.58M
Weighted Avg Shares (Diluted)26.01M26.28M26.57M27.29M28.58M

FENC Earnings Waterfall · TTM

NASDAQ:FENC · Revenue to Net Income

Key Ratios

EPS$-0.31
Gross Margin92.0%
Net Margin-17.8%
P/E Ratio32.4
P/S Ratio19.0

Analysis

$51.0M of revenue converted into -$8.4M of net income for the selected period. Gross margin is 92.0% and net margin is -17.8%, showing how much revenue survives after costs and taxes. EPS is $-0.31, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 12, 2026
4Statement of changes in beneficial ownershipNov 2, 2026
4Statement of changes in beneficial ownershipNov 2, 2026
4Statement of changes in beneficial ownershipNov 2, 2026
4Statement of changes in beneficial ownershipNov 2, 2026

How much revenue does FENC generate?

Fennec Pharmaceuticals Inc. (FENC) reported $44.64M of revenue in fiscal 2025.

Is FENC profitable?

Fennec Pharmaceuticals Inc. (FENC) reported -$9.74M of net income, with a net margin of -21.8%.